Israel's BiondVax To Take 'More Global View' With NASDAQ-Only Listing

 
• By Sten Stovall

BiondVax's CEO tells Scrip why the Israel-based vaccine maker wants to delist there and only have a US-based NASDAQ listing and re-make its executive board in to one that's more internationally experienced.

Nasdaq
BiondVax Says Being Soley NASDAQ-Listed Will Help Make It More Internationally-Minded • Source: Shutterstock

More from Strategy

More from Business